Save Search

1 to 16

Sort By:

Date Target Transaction Type
Value: $mlns
Acquirer Seller
2010-11-01 BioRegen Biomedical
Life Science
Changzhou Jiangsu, China
www.bioregenmed.com

BioRegen Biomedical mainly devotes to research, production and sales of the new high-end pharmaceutical products through the biological modeling repair technology based on sodium hyaluronate and other biological material. BioRegen Biomedical was founded in 2006 and is based in Changzhou Jiangsu, China.

Venture

Ascend Capital Partners
Investor
Merchant Bank
Beijing, China
www.ascendvp.com.cn

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

-
2010-10-20 GlycosBio Food Sciences
Life Science
Houston, Texas
www.glycosbio.com

GlycosBio Food Sciences develops and produces advanced nutritional products. GlycosBio Food Sciences collaborate with scientists and the medical community to design new, highly functional medical foods and nutrition for the 60-70 million patients with digestive diseases. GlycosBio Food Sciences was founded in 2007 and is based in Houston, Texas.

Venture

EIV Capital
Investor
Private Equity Firm
Houston, Texas
www.eivcapital.com

-
2010-10-08 BioDtech, Inc.
Life Science
Birmingham, Alabama
www.biodtechinc.com

BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama.

Venture

Greer Capital Advisors
Investor
Private Equity Firm
Mountain Brook, Alabama
www.greercap.com

-
2010-10-06 Pathwork Diagnostics, Inc.
Life Science
Redwood City, California
www.pathworkdx.com

Pathwork Diagnostics Inc. is a privately held company that develops and delivers innovative molecular diagnostics for oncology. Pathwork's Tissue of Origin Test identifies the source of cancers that are difficult to classify and increases oncologists’ confidence in their treatment approaches. It is the only FDA-approved molecular diagnostic test for tissue of origin.

Venture
Value

$30

Alta Partners
Investor
Venture Capital Firm
San Francisco, California
www.altapartners.com

-
2010-09-29 Sophiris
Life Science
La Jolla, California
www.sophiris.com

Sophiris is a late-stage, clinical biopharmaceutical company developing topsalysin (PRX302) for the treatment of patients with urological diseases. Sophiris was founded in 2002 and is based in La Jolla, California.

Venture

Warburg Pincus
Investor
Private Equity Firm
New York, New York
www.warburgpincus.com

-
Deal Link  
2010-09-01 Dermira, Inc.
Life Science
Menlo Park, California
www.dermira.com

Dermira, Inc. is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. Dermira was founded in 2010 and is based in Menlo Park, California.

Venture

Bay City Capital
Investor
Venture Capital Firm
San Rafael, California
www.baycitycapital.com

-
2010-08-30 Otonomy
Life Science
San Diego, California
www.otonomy.com

Otonomy is an early stage drug development company focused on disorders which are treated by ENT (ear, nose, and throat) doctors, or otolaryngologists. Otonomy was formed in 2008 and is based in San Diego, California.

Venture

TPG
Investor
Private Equity Firm
Fort Worth, Texas
www.tpg.com

-
Deal Article Deal Link  
2010-07-12 Nitric BioTherapeutics
Life Science
Bristol, Pennsylvania
www.nitricbio.com

Nitric BioTherapeutics is a venture-backed biopharmaceutical company dedicated to exploring medical applications of topically applied gaseous Nitric Oxide (gNO). The Company will conduct clinical trials and commercialize gNO for the treatment of non-healing chronic wounds and for the treatment of other topical medical problems such as post-surgical infections.

Venture

NewSpring Capital
Investor
Private Equity Firm
Radnor, Pennsylvania
www.newspringcapital.com

-
2010-06-17 Corridor Pharmaceuticals, Inc.
Life Science
Lutherville, Maryland
www.corridorpharma.com

Corridor Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics for pulmonary arterial hypertension (PAH) and other vascular diseases based on its proprietary serotonin antagonist and arginase inhibition platforms.

Venture

NewSpring Capital
Investor
Private Equity Firm
Radnor, Pennsylvania
www.newspringcapital.com

-
2010-06-15 FoldRx Pharmaceuticals
Life Science
Cambridge, Massachusetts
www.foldrx.com

FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis). The Company's lead product, FX-4006, has begun a Phase II/III study in familial amyloid polyneuropathy. FoldRx Pharmaceuticals was founded in 2003 and is based in Cambridge, Massachusetts.

Venture

Alta Partners
Investor
Venture Capital Firm
San Francisco, California
www.altapartners.com

TPG
Investor
Private Equity Firm
Fort Worth, Texas
www.tpg.com

MPE Partners
Investor
Private Equity Firm
Cleveland, Ohio
www.mpepartners.com

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

-
Deal Link  
2010-04-22 Aragon Pharmaceuticals, Inc.
Life Science
San Diego, California
www.aragonpharm.com

Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company focused on developing breakthrough medicines for the treatment of hormonally-driven cancers.

Venture

Aisling Capital
Investor
Private Equity Firm
New York, New York
www.aislingcapital.com

-
Deal Article Deal Link  
2010-04-13 AltheaDx
Life Science
San Diego, California
www.altheadx.com

AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenetics, or PGx. AltheaDx's product testing portfolio enables personalized therapeutic decisions for patients suffering from some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders, and pain. AltheaDx was founded in 1998 and is based in San Diego, California.

Venture

Telegraph Hill Partners
Investor
Venture Capital Firm
San Francisco, California
www.thpartners.net

-
Deal Article
2010-04-07 Achaogen
Life Science
San Francisco, California

Achaogen is a bio-pharmaceutical company developing treatments for life-threatening infections caused by multi-drug resistant (MDR) Gram-negative bacteria, an area of critical unmet medical need. Achaogen was formed in 2002 and is based in San Francisco, California.

Venture

Alta Partners
Investor
Venture Capital Firm
San Francisco, California
www.altapartners.com

-
2010-04-05 Altheos
Life Science
San Francisco, California
www.altheos.net

Altheos is a privately held, clinical stage biopharmaceutical company focused on the development of next-generation drugs that address the unmet medical needs of patients worldwide in ophthalmology, including best-in-class treatments for glaucoma.

Venture

Bay City Capital
Investor
Venture Capital Firm
San Rafael, California
www.baycitycapital.com

-
Deal Article Deal Link  
2010-04-04 Shanghai Hile Bio-Technology
Life Science
Shanghai, China
www.hile-bio.com

Shanghai Hile Bio-Technology researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. Shanghai Hile Bio-Technology was founded in 1981 and is based in Shanghai, China.

Venture

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

-
2010-03-22 Nodality
Life Science
San Francisco, California
www.nodalityinc.com

Nodality is a biotechnology company, discovers and develops personal diagnostics in cell-signaling pathway nodes detected in cellular subpopulations from patients. Nodality focuses on hematological and autoimmune disorders. Nodality was founded in 2003 and is based in San Francisco, California.

Venture

TPG
Investor
Private Equity Firm
Fort Worth, Texas
www.tpg.com

-
Avg $30
0.0x EBITDA
0.0x REVENUE

Try Mergr Free — Access the Full List Today

Stop Manually Tracking Deals.
Get Full Access. Cancel Anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.

Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.

The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.